Publications by authors named "Steven L Bramer"

Claim this Profile
E
Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.
Suresh Mallikaarjun, Susan E Shoaf, David W Boulton, Steven L Bramer

Clin Pharmacokinet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide.
Susan E Shoaf, Steven L Bramer, Patricia Bricmont, Christopher A Zimmer

J Cardiovasc Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two doses and dosing regimens of tolvaptan in congestive heart failure.
Paul J Hauptman, Christopher Zimmer, James Udelson, Susan E Shoaf, Suresh Mallikaarjun, Steven L Bramer

J Cardiovasc Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias.
Susan Elizabeth Shoaf, Marcelo Víctor Elizari, Zhao Wang, Kumara Sekar, Liliana Rosa Grinfeld, Steven Lee Bramer

J Cardiovasc Pharmacol Ther· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations in study designs that use cotinine as a biomarker.
Steven L Bramer, Beatrice A Kallungal

Biomarkers· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.
Suresh Mallikaarjun, Daniel E Salazar, Steven L Bramer

J Clin Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended application of an LC-MS/MS method for the analysis of vesnarinone and its metabolites in human urine and dialysate fluid.
Kumara S Sekar, Steven L Bramer

J Pharm Biomed Anal· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.
Brinda Tammara, John M Trang, Mami Kitani, Gohachiro Miyamoto, Steven L Bramer

J Clin Pharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
Shailesh S Vengurlekar, Jennifer Heitkamp, Fred McCush, Poonam R Velagaleti, Jerry H Brisson, Steven L Bramer

J Pharm Biomed Anal· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6.
Brinda Tammara, John M Trang, Gohachiro Miyamoto, Mami Kitani, Jerry Brisson, Steven L Bramer

J Clin Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis